Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$297,458
+$69,356 QoQ
Shares Held
248
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#4,164
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Haven Capital Group, Inc. holds $6,551,690 across 4 Drug Manufacturers - General names. LLY ranks #4 (4.5% of the industry book) .
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,458 | 248 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $228,102 | 248 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $266,520 | 248 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $231,189 | 303 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $236,197 | 303 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $251,076 | 304 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||